213 related articles for article (PubMed ID: 28905207)
1. Role of vasopressin V1a receptor in ∆
Egashira N; Koushi E; Myose T; Tanoue A; Mishima K; Tsuchihashi R; Kinjo J; Tanaka H; Morimoto S; Iwasaki K
Psychopharmacology (Berl); 2017 Dec; 234(23-24):3475-3483. PubMed ID: 28905207
[TBL] [Abstract][Full Text] [Related]
2. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
Egashira N; Matsuda T; Koushi E; Mishima K; Iwasaki K; Shoyama Y; Fujiwara M
Eur J Pharmacol; 2006 Nov; 550(1-3):117-22. PubMed ID: 17022969
[TBL] [Abstract][Full Text] [Related]
3. Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.
Sano K; Mishima K; Koushi E; Orito K; Egashira N; Irie K; Takasaki K; Katsurabayashi S; Iwasaki K; Uchida N; Egawa T; Kitamura Y; Nishimura R; Fujiwara M
Neuroscience; 2008 Jan; 151(2):320-8. PubMed ID: 18083311
[TBL] [Abstract][Full Text] [Related]
4. 2,5-Dimethoxy-4-iodoamphetamine (DOI) inhibits Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
Egashira N; Koushi E; Mishima K; Iwasaki K; Oishi R; Fujiwara M
J Pharmacol Sci; 2007 Dec; 105(4):361-6. PubMed ID: 18057774
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the cataleptic effect of tetrahydrocannabinol by other constituents of Cannabis sativa L.
Formukong EA; Evans AT; Evans FJ
J Pharm Pharmacol; 1988 Feb; 40(2):132-4. PubMed ID: 2897447
[TBL] [Abstract][Full Text] [Related]
6. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
[TBL] [Abstract][Full Text] [Related]
7. Differential glutamatergic and GABAergic contributions to the tetrad effects of Δ
De Giacomo V; Ruehle S; Lutz B; Häring M; Remmers F
Neuropharmacology; 2020 Nov; 179():108287. PubMed ID: 32860777
[TBL] [Abstract][Full Text] [Related]
8. Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Kinoshita H; Hasegawa T; Kameyama T; Yamamoto I; Nabeshima T
Neurosci Lett; 1994 Jun; 174(1):101-4. PubMed ID: 7970141
[TBL] [Abstract][Full Text] [Related]
9. Effect of dizocilpine (MK-801) on the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Kinoshita H; Hasegawa T; Katsumata Y; Kameyama T; Yamamoto I; Nabeshima T
J Neural Transm Gen Sect; 1994; 95(2):137-43. PubMed ID: 7865168
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid-Induced Tetrad in Mice.
Metna-Laurent M; Mondésir M; Grel A; Vallée M; Piazza PV
Curr Protoc Neurosci; 2017 Jul; 80():9.59.1-9.59.10. PubMed ID: 28678398
[TBL] [Abstract][Full Text] [Related]
11. Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications.
Marchese G; Casti P; Ruiu S; Saba P; Sanna A; Casu G; Pani L
Br J Pharmacol; 2003 Oct; 140(3):520-6. PubMed ID: 12970091
[TBL] [Abstract][Full Text] [Related]
12. Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice.
Bielsky IF; Hu SB; Szegda KL; Westphal H; Young LJ
Neuropsychopharmacology; 2004 Mar; 29(3):483-93. PubMed ID: 14647484
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
El-Alfy AT; Ivey K; Robinson K; Ahmed S; Radwan M; Slade D; Khan I; ElSohly M; Ross S
Pharmacol Biochem Behav; 2010 Jun; 95(4):434-42. PubMed ID: 20332000
[TBL] [Abstract][Full Text] [Related]
14. The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.
Reymond-Marron I; Tribollet E; Raggenbass M
Eur J Neurosci; 2006 Sep; 24(6):1565-74. PubMed ID: 17004920
[TBL] [Abstract][Full Text] [Related]
15. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ
Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443
[TBL] [Abstract][Full Text] [Related]
16. Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat.
Prescott WR; Gold LH; Martin BR
Psychopharmacology (Berl); 1992; 107(1):117-24. PubMed ID: 1317040
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin V1A receptor enhances baroreflex via the central component of the reflex arc.
Oikawa R; Nasa Y; Ishii R; Kuwaki T; Tanoue A; Tsujimoto G; Takeo S
Eur J Pharmacol; 2007 Mar; 558(1-3):144-50. PubMed ID: 17224142
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
19. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
[TBL] [Abstract][Full Text] [Related]
20. New topics in vasopressin receptors and approach to novel drugs: role of the vasopressin receptor in psychological and cognitive functions.
Egashira N; Mishima K; Iwasaki K; Oishi R; Fujiwara M
J Pharmacol Sci; 2009 Jan; 109(1):44-9. PubMed ID: 19151541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
